Functional assays which provide an integrated view of all possible checkpoints that are operative can complement current methods to select the right drug for each patient in clinical trials and clinical practice.
Plexision’s functional assays characterize tumor antigenicity and anti-tumor responses and their modulation with specific immune checkpoint inhibitors. These assays use tumor cells or purified tumor antigens and can be used in clinical trials.
Plexision’s functional test systems are performed in its GLP- and cGMP-compliant CLIA-approved reference laboratory.